Burning Rock Biotech BNR
NASDAQ BNR
$17.63 -1.31 (-6.92%)
At close: Sep 30, 2026 · 4:00 PM EDT

Burning Rock Biotech (BNR) Convertible Debt (2023)

Updated

Burning Rock Biotech's Convertible Debt was $738,881 in the quarter ended Dec 31, 2023.

Analysis

Burning Rock Biotech (BNR) Convertible Debt (2023) Analysis & Trends

As of Dec 31, 2023, Convertible Debt at Burning Rock Biotech came in at $752,793.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 94.08 Bn 93.52 Bn -
2 Natera 59.53 Bn 55.21 Bn 485.19 Mn
3 Quest Diagnostics 25.60 Bn 24.03 Bn 1.03 Bn
4 Labcorp Holdings 24.98 Bn 22.75 Bn 1.11 Bn
5 Guardant Health 23.75 Bn 19.81 Bn 219.03 Mn
6 Tenet Healthcare 20.75 Bn 11.90 Bn -
7 Tempus AI 14.47 Bn 11.50 Bn 246.50 Mn
8 Encompass Health 12.19 Bn 12.65 Bn -
9 Davita 11.20 Bn 9.97 Bn 1.16 Bn
10 Burning Rock Biotech 199.22 Mn -58.93 Mn 14.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 738,880.93
API Access

Burning Rock Biotech Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=BNR&period=max&api_key=YOUR_API_KEY